{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:48:56Z","timestamp":1793922536588,"version":"4.8.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,8]],"date-time":"2013-07-08T00:00:00Z","timestamp":1373241600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1940-0640-8-12","type":"journal-article","created":{"date-parts":[[2013,7,8]],"date-time":"2013-07-08T18:14:04Z","timestamp":1373307244000},"source":"Crossref","is-referenced-by-count":31,"title":["Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration"],"prefix":"10.1186","volume":"8","author":[{"given":"A C","family":"Del Re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lembke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex HS","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,8]]},"reference":[{"key":"137_CR1","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1176\/ps.2010.61.4.392","volume":"61","author":"A Harris","year":"2010","unstructured":"Harris A, Kivlahan D, Bowe T, Humphreys K: Pharmacotherapy of alcohol use disorders in the Veterans Health Administration. Psychiatr Serv. 2010, 61: 392-398. 10.1176\/appi.ps.61.4.392.","journal-title":"Psychiatr Serv"},{"key":"137_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/alcalc\/36.1.2","volume":"36","author":"JD Sinclair","year":"2001","unstructured":"Sinclair JD: Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol Alcohol. 2001, 36: 2-10. 10.1093\/alcalc\/36.1.2.","journal-title":"Alcohol Alcohol"},{"key":"137_CR3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jpsychires.2006.02.002","volume":"40","author":"BJ Mason","year":"2006","unstructured":"Mason BJ, Goodman AM, Chabac S, Lehert P: Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation. J Psychiatr Res. 2006, 40: 383-393. 10.1016\/j.jpsychires.2006.02.002.","journal-title":"J Psychiatr Res"},{"key":"137_CR4","volume-title":"Guideline Summary","author":"VA\/DOD Clinical Practice Guidelines for Management of Substance Use Disorder (SUD)","year":"2009","unstructured":"VA\/DOD Clinical Practice Guidelines for Management of Substance Use Disorder (SUD): Guideline Summary. 2009, Washington, DC: US Department of Veterans Affairs\/Department of Defense"},{"key":"137_CR5","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/j.1475-6773.2007.00812.x","volume":"43","author":"CJ Heinrich","year":"2007","unstructured":"Heinrich CJ, Hill CJ: Role of state policies in the adoption of naltrexone for substance abuse treatment. Health Serv Res. 2007, 43: 951-970. 10.1111\/j.1475-6773.2007.00812.x.","journal-title":"Health Serv Res"},{"key":"137_CR6","first-page":"275","volume-title":"Rethinking Substance Abuse: What the Science Shows and What We Should Do About It","author":"AT McLellan","year":"2006","unstructured":"McLellan AT: What we need is a system: creating a responsive and effective substance abuse treatment system. Rethinking Substance Abuse: What the Science Shows and What We Should Do About It. Edited by: Miller WR. 2006, New York: Guilford, 275-292."},{"key":"137_CR7","first-page":"8","volume":"38","author":"B Arbaizar","year":"2010","unstructured":"Arbaizar B, Diersen-Sotos T, G\u00f3mez-Acebo I, Llorca J: Topiramate in the treatment of alcohol dependence: a meta-analysis. Actas Esp Psiquiatr. 2010, 38: 8-12.","journal-title":"Actas Esp Psiquiatr"},{"key":"137_CR8","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1001\/jama.298.14.1641","volume":"298","author":"BA Johnson","year":"2007","unstructured":"Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O\u2019Malley SS, Swift RM: Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA. 2007, 298: 1641-1651. 10.1001\/jama.298.14.1641.","journal-title":"JAMA"},{"key":"137_CR9","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1345\/aph.1L157","volume":"42","author":"CL Olmsted","year":"2008","unstructured":"Olmsted CL, Kockler DR: Topiramate for alcohol dependence. Ann Pharmacother. 2008, 42: 1475-1480. 10.1345\/aph.1L157.","journal-title":"Ann Pharmacother"},{"key":"137_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2174\/1874473710902020135","volume":"2","author":"GA Kenna","year":"2009","unstructured":"Kenna GA, Lomastro TL, Schiesl A, Leggio L, Swift RM: Review of topiramate: an antiepileptic for the treatment of alcohol dependence. Curr Drug Abuse Rev. 2009, 2: 135-142. 10.2174\/1874473710902020135.","journal-title":"Curr Drug Abuse Rev"},{"key":"137_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1744-859X-4-5","volume":"4","author":"D Arnone","year":"2005","unstructured":"Arnone D: Review of the use of topiramate for treatment of psychiatric disorders. Ann Gen Psychiatry. 2005, 4: 5-10.1186\/1744-859X-4-5.","journal-title":"Ann Gen Psychiatry"},{"key":"137_CR12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2190\/PM.42.3.b","volume":"42","author":"PM Miller","year":"2011","unstructured":"Miller PM, Book SW, Stewart SH: Medical treatment of alcohol dependence: a systematic Review. Int J Psychiatry Med. 2011, 42: 227-266. 10.2190\/PM.42.3.b.","journal-title":"Int J Psychiatry Med"},{"key":"137_CR13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.7326\/0003-4819-142-7-200504050-00012","volume":"142","author":"Z Li","year":"2005","unstructured":"Li Z, Maglione M, Tu W, Mojica W, Arterburn D, Shugarman LR, Hilton L, Suttorp M, Solomon V, Shekelle PG: Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med. 2005, 142: 532-546. 10.7326\/0003-4819-142-7-200504050-00012.","journal-title":"Ann Intern Med"},{"key":"137_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1176\/appi.ajp.160.2.255","volume":"160","author":"SL McElroy","year":"2003","unstructured":"McElroy SL, Arnold LM, Shapira NA, Keck PE, Rosenthal NR, Karim MR, Kamin M, Hudson JI: Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry. 2003, 160: 255-261. 10.1176\/appi.ajp.160.2.255.","journal-title":"Am J Psychiatry"},{"key":"137_CR15","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1001\/jama.291.8.965","volume":"291","author":"JL Brandes","year":"2004","unstructured":"Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, Neto W, Schwabe S, Jacobs D: Topiramate for migraine prevention. JAMA. 2004, 291: 965-973. 10.1001\/jama.291.8.965.","journal-title":"JAMA"},{"key":"137_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1192\/bjp.bp.108.062984","volume":"196","author":"K Lieb","year":"2010","unstructured":"Lieb K, V\u00f6llm B, R\u00fccker G, Timmer A, Stoffers JM: Pharmacotherapy for borderline personality disorder: cochrane systematic review of randomised trials. Brit J Psychiatry. 2010, 196: 4-12. 10.1192\/bjp.bp.108.062984.","journal-title":"Brit J Psychiatry"},{"key":"137_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4088\/JCP.v63n0104","volume":"63","author":"J Berlant","year":"2002","unstructured":"Berlant J, Van Kammen DP: Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report. J Clin Psychiatry. 2002, 63: 15-20. 10.4088\/JCP.v63n0104.","journal-title":"J Clin Psychiatry"},{"key":"137_CR18","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1176\/appi.ps.201000553","volume":"63","author":"AHS Harris","year":"2012","unstructured":"Harris AHS, Oliva E, Bowe T, Humphreys KN, Kivlahan DR, Trafton JA: Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence. Psychiatr Serv. 2012, 63: 679-685.","journal-title":"Psychiatr Serv"},{"issue":"3 Suppl 1","key":"137_CR19","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1097\/MLR.0b013e31827da836","volume":"51","author":"JA Trafton","year":"2013","unstructured":"Trafton JA, Greenberg G, Harris AHS, Tavakoli S, Kearney L, McCarthy J, Blow F, Desai R, Schohn M: VHA mental health information system: applying health information technology to monitor and facilitate implementation of VHA Uniform Mental Health Services Handbook requirements. Med Care. 2013, 51 (3 Suppl 1): S29-36.","journal-title":"Med Care"},{"key":"137_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jsat.2013.01.004","volume":"45","author":"CP Thomas","year":"2013","unstructured":"Thomas CP, Garnick DW, Horgan CM, Miller K, Harris AH, Rosen MM: Establishing the feasibility of measuring performance in use of addiction pharmacotherapy. J Subst Abuse Treat. 2013, 45: 11-18. 10.1016\/j.jsat.2013.01.004.","journal-title":"J Subst Abuse Treat"},{"key":"137_CR21","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","volume":"361","author":"BA Johnson","year":"2003","unstructured":"Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, Javors MA, Ma JZ: Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet. 2003, 361: 1677-1685. 10.1016\/S0140-6736(03)13370-3.","journal-title":"Lancet"},{"key":"137_CR22","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1111\/j.1360-0443.2008.02355.x","volume":"103","author":"DA Baltieri","year":"2008","unstructured":"Baltieri DA, Dar\u00f3 FR, Ribeiro PL, De Andrade AG: Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction. 2008, 103: 2035-2044. 10.1111\/j.1360-0443.2008.02355.x.","journal-title":"Addiction"},{"key":"137_CR23","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/JCP.0b013e3181bfdb79","volume":"29","author":"G Rubio","year":"2009","unstructured":"Rubio G, Martinez-Gras I, Manzanares J: Modulation of impulsivity by topiramate: implications for the treatment of alcohol dependence. J Clin Psychopharmacol. 2009, 29: 584-589. 10.1097\/JCP.0b013e3181bfdb79.","journal-title":"J Clin Psychopharmacol"},{"key":"137_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jsat.2010.08.005","volume":"40","author":"CP Thomas","year":"2011","unstructured":"Thomas CP, Garnick DW, Horgan CM, McCorry F, Gmyrek A, Chalk M, Gastfriend DR, Rinaldo SG, Albright J, Capoccia VA: Advancing performance measures for use of medications in substance abuse treatment. J Subst Abuse Treat. 2011, 40: 35-43. 10.1016\/j.jsat.2010.08.005.","journal-title":"J Subst Abuse Treat"},{"key":"137_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-244X-11-41","volume":"11","author":"T Paparrigopoulos","year":"2011","unstructured":"Paparrigopoulos T, Tzavellas E, Karaiskos D, Kourlaba G, Liappas I: Treatment of alcohol dependence with low-dose topiramate: an open-label controlled study. BMC Psychiatry. 2011, 11: 41-10.1186\/1471-244X-11-41.","journal-title":"BMC Psychiatry"},{"key":"137_CR26","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1037\/1541-1559.5.3.228","volume":"5","author":"AH Harris","year":"2008","unstructured":"Harris AH, Bowe T: Predictors of initiation and engagement in VA substance use disorder (SUD) treatment. Psychol Serv. 2008, 5: 228-","journal-title":"Psychol Serv"}],"container-title":["Addiction Science & Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1940-0640-8-12.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1940-0640-8-12\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1940-0640-8-12.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T05:43:54Z","timestamp":1548222234000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/1940-0640-8-12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,8]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["137"],"URL":"https:\/\/doi.org\/10.1186\/1940-0640-8-12","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,8]]},"article-number":"12"}}